Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration

Toxicology and Applied Pharmacology

Volumn 312, Issue , 2016, Pages 11-18

  Ngalame, Ntube N O ^a   Makia, Ngome L ^a   Waalkes, Michael P ^a   Tokar, Erik J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Arsenic; Cancer; miRNA; Prostate; Stem cells

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; COFILIN; GELATINASE A; GELATINASE B; LIM KINASE 1; MICRORNA 143; PROTEIN BCL 2; PROTEIN BCL XL; CARCINOGEN; LIM KINASE; LIMK1 PROTEIN, HUMAN; MATRIX METALLOPROTEINASE; MICRORNA; MIRN143 MICRORNA, HUMAN;

ABCG2 GENE; APOPTOSIS; ARTICLE; BMI 1 GENE; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME RELEASE; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LENTIVIRINAE; MALIGNANT TRANSFORMATION; MULTIPLE CANCER; NOTCH 1 GENE; OCT4 GENE; PHENOTYPE; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; CHEMICALLY INDUCED; GENETICS; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ARSENIC; CARCINOGENS; CELL LINE, TUMOR; HUMANS; LIM KINASES; MALE; MATRIX METALLOPROTEINASES; MICRORNAS; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS;

EID: 84960860728     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.12.013     Document Type: Article

References (59)

1. Achanzar, W.E., Brambila, E.M., Diwan, B.A., Webber, M.M., Waalkes, M.P., Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. J. Natl. Cancer Inst. 94 (2002), 1888–1891.
2. Ahmad, I., Singh, L.B., Yang, Z.H., Kalna, G., Fleming, J., Fisher, G., et al. Mir-143 expression inversely correlates with nuclear Erk5 immunoreactivity in clinical prostate cancer. Br. J. Cancer 108 (2013), 149–154.
3. Ahmed, T., Shea, K., Masters, J.R., Jones, G.E., Wells, C.M., A pak4–limk1 pathway drives prostate cancer cell migration downstream of HGF. Cell. Signal. 20 (2008), 1320–1328.
4. Akao, Y., Nakagawa, Y., Iio, A., et al. Role of miRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. Leuk. Res. 33 (2009), 1530–1538.
5. Bachmeier, B.E., Boukamp, P., Lichtinghagen, R., Fusenig, N.E., Fink, E., Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol. Chem. 381 (2000), 497–507.
6. Benbrahim-Tallaa, L., Waalkes, M.P., Inorganic arsenic and human prostate cancer. Environ. Health Perspect. 116 (2008), 158–164.
7. Bomken, S., Fiser, K., Heidenreich, O., Vormoor, J., Understanding the cancer stem cell. Br. J. Cancer 103 (2010), 439–445.
8. Borensztajn, K., Peppelenbosch, M.P., Spek, C.A., Coagulation Factor Xa inhibits cancer cell migration via Limk1-mediated cofilin inactivation. Thromb. Res. 125 (2010), e323–e328.
9. Borovski, T., De Sousa, E.M.F., Vermeulen, L., Medema, J.P., Cancer stem cell niche: the place to be. Cancer Res. 71 (2011), 634–639.
10. Calin, G.A., Croce, C.M., MicroRNA signatures in human cancers. Nat. Rev. Cancer 6 (2006), 857–866.
11. Clape, C., Fritz, V., Henriquet, C., Apparailly, F., Fernandez, P.L., Iborra, F., et al. Mir-143 interferes with Erk5 signaling, and abrogates prostate cancer progression in mice. PLoS ONE, 4, 2009, e7542.
12. Davila, M., Frost, A.R., Grizzle, W.E., Chakrabarti, R., Lim kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J. Biol. Chem. 278 (2003), 36868–36875.
13. Davila, M., Jhala, D., Ghosh, D., Grizzle, W.E., Chakrabarti, R., Expression of Lim kinase 1 is associated with reversible G1/S phase arrest, chromosomal instability and prostate cancer. Mol. Cancer, 6, 2007, 40.
14. Hanahan, D., Weinberg, R.A., The hallmarks of cancer. Cell 100 (2000), 57–70.
15. Hochedlinger, K., Yamada, Y., Beard, C., Jaenisch, R., Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121 (2005), 465–477.
16. Huang, S., Guo, W., Tang, Y., Ren, D., Zou, X., Peng, X., Mir-143 and Mir-145 inhibit stem cell characteristics of PC-3 prostate cancer cells. Oncol. Rep. 28 (2012), 1831–1837.
17. Huss, W.J., Greenberg, N.M., Mohler, J.L., Smith, G.J., Breast cancer resistant protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Cancer Res. 65 (2005), 6640–6650.
18. IARC, (International Agency for Research on Cancer) arsenic and arsenic compounds. IARC Monogr. Eval. Carcinog. Risks Hum. 100C (2012), 41–94.
19. Iliopoulos, D., Hirsch, H.A., Wang, G., Struhl, K., Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via Il6 secretion. Proc. Natl. Acad. Sci. 108 (2010), 1397–1402.
20. Kessenbrock, K., Plaks, V., Werb, Z., Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141 (2010), 52–67.
21. Leong, K.G., Gao, W.-Q., The Notch pathway in prostate development and cancer. Differentiation 76 (2008), 699–716.
22. Lessard, J., Sauvageau, G., BMI-1 determines the proliferative capacity of normal and leukemic stem cells. Nature 423 (2003), 255–260.
23. Li, R., Zhang, L., Jia, L., Duan, Y., Li, Y., Wang, J., et al. MicroRNA-143 targets Syndecan-1 to repress cell growth in melanoma. PLoS One, 9, 2014, e94855.
24. Lipeng, L., Xiaohua, Y., Xiaofang, G., Zhi, T., Min, S., Yu, L., et al. Mir-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. Mol. Med. Rep. 5 (2012), 753–760.
25. Liu, C., Tang, D.G., MicroRNA regulation of cancer stem cells. Cancer Res. 71 (2011), 5950–5954.
26. Liu, C., Kelnar, K., Vlassov, A.V., Brown, D., Wang, J., Tang, D.G., Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res. 72 (2012), 3393–3404.
27. Manetti, F., Lim kinases are attractive targets with many macromolecular partners and only a few small molecule regulators. Med. Res. Rev. 32 (2012), 968–998.
28. Ngalame, N.N., Tokar, E.J., Person, R.J., Waalkes, M.P., Silencing Kras overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype. Toxicol. Sci. 142 (2014), 489–496.
29. Ngalame, N.N., Tokar, E.J., Person, R.J., Xu, Y., Waalkes, M.P., Aberrant microRNA expression likely controls ras oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic. Toxicol. Sci. 138 (2014), 268–277.
30. Ni, Z., Yunshu, S., Lijun, X., Targeting PKCe by mir-143 regulates cell apoptosis in lung cancer. FEBS Lett. 587 (2013), 3661–3667.
31. Noguchi, S., Mori, T., Hoshino, Y., et al. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett. 307 (2011), 211–220.
32. Okamoto, I., Pirker, C., Bilban, M., Berger, W., Losert, D., Marosi, C., et al. Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma. Neoplasia 7 (2005), 303–311.
33. Osaki, M., Takeshita, F., Sugimoto, Y., et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprtease-13 expression. Mol. Ther. 19 (2011), 1123–1130.
34. Pardal, R., Clarke, M.F., Morrison, S.J., Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3 (2003), 895–902.
35. Porkka, K.P., Pfeiffer, M.J., Waltering, K.K., Vessella, R.L., Tammela, T.L., Visakorpi, T., MicroRNA expression profiling in prostate cancer. Cancer Res. 67 (2007), 6130–6135.
36. Pramanik, D., Campbell, N.R., Karikari, C., et al. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 10 (2011), 1470–1480.
37. Radisky, E.S., Radisky, D.C., Matrix metalloproteinase-induced epithelial–mesenchymal transition in breast cancer. J. Mammary Gland Biol. Neoplasia 15 (2010), 201–212.
38. Reya, T., Morrison, S.J., Clarke, M.F., Weismann, I.L., Stem cells, cancer, and cancer stem cells. Nature 414 (2001), 105–111.
39. Rosen, J.M., Jordan, C.T., The increasing complexity of the cancer stem cell paradigm. Science 324 (2009), 1670–1673.
40. Salmon, P., Trono, D., Production and titration of lentiviral vectors. Curr. Protoc. Neurosci., 2006 (Chapter 4:Unit 4.21).
41. Scott, R.W., Olson, M.F., Lim kinases: function, regulation and association with human disease. J. Mol. Med., 2007, 85.
42. Shen, J.Z., Zhang, Y.Y., Fu, H.Y., Wu, D.S., Zhou, H.R., Overexpression of microRNA-143 inhibits growth and induces apoptosis in human leukemia cells. Oncol. Rep. 31 (2014), 2035–2042.
43. Stetler-Stevenson, W.G., Hewitt, R., Corcoran, M., Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin. Cancer Biol. 7 (1996), 147–154.
44. Sun, Y., Tokar, E.J., Waalkes, M.P., Overabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenic. Toxicol. Sci. 125 (2012), 20–29.
45. Takagi, T., Iio, A., Nakagawa, Y., Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 77 (2009), 12–21.
46. Tay, Y.M., Tam, W.L., Ang, Y.S., Gaughwin, P.M., Yang, H., Wang, W., et al. MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1. Stem Cells 26 (2008), 17–29.
47. Tokar, E.J., Ancrile, B.B., Cunha, G.R., Webber, M.M., Stem/progenitor and intermediate cell types and the origin of human prostate cancer. Differentiation 73 (2005), 463–473.
48. Tokar, E.J., Diwan, B.A., Waalkes, M.P., Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype. Environ. Health Perspect. 118 (2010), 108–115.
49. Tokar, E.J., Qu, W., Liu, J., Liu, W., Webber, M.M., Phang, J.M., et al. Arsenic-specific stem cell selection during malignant transformation. J. Natl. Cancer Inst. 102 (2010), 638–649.
50. Tokar, E.J., Diwan, B.A., Ward, J.M., Delker, D.A., Waalkes, M.P., Carcinogenic effects of “whole-life” exposure to inorganic arsenic in CD1 mice. Toxicol. Sci. 119 (2011), 73–83.
51. Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 2257–2261.
52. Waalkes, M.P., Liu, J., Diwan, B.A., Transplacental arsenic carcinogenesis in mice. Toxicol. Appl. Pharmacol. 222 (2007), 271–280.
53. Waalkes, M.P., Liu, J., Germolec, D.R., Trempus, C.S., Cannon, R.E., Tokar, E.J., et al. Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer Res. 68 (2008), 8278–8285.
54. Wang, J.C., Good cells gone bad: the cellular origins of cancer. Trends Mol. Med. 16 (2010), 145–151.
55. Xia, H., Sun, S., Wang, B., Wang, T., Liang, C., Li, G., et al. Mir-143 inhibits NSCLC cell growth and metastasis by targeting Limk1. Int. J. Mol. Sci. 15 (2014), 11973–11983.
56. Xu, B., Niu, X., Zhang, X., Tao, J., Wu, D., Wang, Z., et al. Mir-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Mol. Cell. Biochem. 350 (2011), 207–213.
57. Yoshioka, K., Foletta, V., Bernard, O., Itoh, K., A role for Lim kinase in cancer invasion. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 7247–7252.
58. Zhang, Y., Wang, Z., Chen, M., et al. MicroRNA-143 targets MACCI to inhibit cell invasion and migration in colorectal cancer. Mol. Cancer, 11, 2012, 23.
59. Zhou, S., Schuetz, J.D., Bunting, K.D., Colapietro, A.M., Sampath, J., Morris, J.J., et al. The ABC transporter bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7 (2001), 1028–1034.